Brokerages Set Sotera Health (NASDAQ:SHC) Price Target at $16.08

Sotera Health (NASDAQ:SHC) has been given an average rating of “Moderate Buy” by the six brokerages that are currently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $15.92.

A number of brokerages have recently weighed in on SHC. Royal Bank of Canada reissued an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a report on Thursday, November 21st. Citigroup boosted their target price on shares of Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, November 6th. The Goldman Sachs Group began coverage on shares of Sotera Health in a research report on Friday, December 6th. They set a “neutral” rating and a $14.00 target price for the company. Finally, Barclays decreased their target price on shares of Sotera Health from $17.00 to $16.00 and set an “overweight” rating for the company in a research report on Friday.

Sotera Health Price Performance

Shares of SHC opened at $12.47 on Friday. The firm has a market capitalization of $3.53 billion, a PE ratio of 49.88 and a beta of 1.91. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. Sotera Health has a 1-year low of $10.71 and a 1-year high of $17.08. The company’s fifty day moving average price is $13.45 and its 200-day moving average price is $14.51.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of SHC. Blue Trust Inc. raised its position in shares of Sotera Health by 164.3% in the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock worth $25,000 after acquiring an additional 1,140 shares during the period. Quarry LP acquired a new position in shares of Sotera Health in the fourth quarter worth about $28,000. True Wealth Design LLC acquired a new position in shares of Sotera Health in the third quarter worth about $32,000. GAMMA Investing LLC raised its position in shares of Sotera Health by 37.5% in the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after acquiring an additional 1,121 shares during the period. Finally, Tower Research Capital LLC TRC raised its position in shares of Sotera Health by 37.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company’s stock worth $82,000 after acquiring an additional 1,640 shares during the period. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.